LAUSR

Iron is an essential micronutrient for life. Its redox activity is a key component in a plethora of vital enzymatic reactions that take place in processes such as drug metabolism, DNA synthesis, steroid synthesis, gene regulation, and cellular respiration (oxygen transport and the electron transport chain). Bacteria are highly dependent on iron for their survival and growth, and have specific mechanisms to acquire iron. Limiting the availability of iron to bacteria thereby preventing its growth provides new opportunities to treat infection in the era of the persistent rise of antibiotic resistant bacteria. In this work, we have developed macromolecular iron chelators, conjugates of a high affinity iron chelator (HBEDS) with polyglycerol, in an attempt to sequester iron-uptake by bacteria to limit their growth in order to enhance antibiotic activity. The new macromolecular chelators are successful in slowing the growth of S. aureus and worked as an efficient bacteriostatic against S. aureus. Further, these cytocompatible macrochelators acted as effective adjuvants to prevent bacterial growth when used in conjunction with antibiotics. The adjuvant activity of the macrochelators depends on their molecular weight and the chelator density on these molecules. These selective macro iron (III) chelators are highly efficient in growth inhibition and killing of Methicillin-resistant Staphylococcus aureus (MRSA) in conjunction with a low concentration of rifampicin.